Valeant Pharmaceuticals International Inc received a takeover approach this spring from Takeda Pharmaceutical Co and investment firm TPG, which it rejected, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
Specialty drugmaker Valeant has been struggling to revive itself after its business model and drug pricing practices came under scrutiny, and it recently brought in a new CEO, Joseph Papa. The Takeda-TPG approach — which did not include a firm price — was made before Papa’s appointment, and there are no talks under way currently, the Journal reported.
Papa on Monday said at the UBS Global Healthcare Conference that Valeant has a “very good pipeline” of new drugs that has not been fully appreciated.
The board is giving Papa time to set a new course for the Laval, Quebec-based drugmaker, the Journal said.
Representatives for three firms declined to comment.
Valeant bought Salix Pharmaceuticals Ltd last year, gaining access to a portfolio of gastrointestinal treatments, a disease area Takeda is focusing on.
Osaka-based Takeda is Japan’s largest pharmaceutical company, and CEO Christophe Weber has repeatedly stated his ambitions to make the company a global leader in oncology and gastrointestinal treatments and to gain control of new drugs the company can develop to sell worldwide.
The Japanese drugmaker spent more than US$21 billion on its two biggest acquisitions, purchasing Millennium Pharmaceuticals Inc to expand in cancer therapies in 2008 and Zurich-based Nycomed in 2011 to grow in emerging markets.
A deal with Valeant would have given Takeda access to Xifaxan, a potential blockbuster drug for irritable bowel syndrome.
TPG, whose main offices are in San Francisco and Fort Worth, Texas, has more than US$70 billion under management and has invested in all sectors of healthcare, including hospitals, biotechnology firms and insurers.
NOT JUSTIFIED: The bank’s governor said there would only be a rate cut if inflation falls below 1.5% and economic conditions deteriorate, which have not been detected The central bank yesterday kept its key interest rates unchanged for a fifth consecutive quarter, aligning with market expectations, while slightly lowering its inflation outlook amid signs of cooling price pressures. The move came after the US Federal Reserve held rates steady overnight, despite pressure from US President Donald Trump to cut borrowing costs. Central bank board members unanimously voted to maintain the discount rate at 2 percent, the secured loan rate at 2.375 percent and the overnight lending rate at 4.25 percent. “We consider the policy decision appropriate, although it suggests tightening leaning after factoring in slackening inflation and stable GDP growth,”
DIVIDED VIEWS: Although the Fed agreed on holding rates steady, some officials see no rate cuts for this year, while 10 policymakers foresee two or more cuts There are a lot of unknowns about the outlook for the economy and interest rates, but US Federal Reserve Chair Jerome Powell signaled at least one thing seems certain: Higher prices are coming. Fed policymakers voted unanimously to hold interest rates steady at a range of 4.25 percent to 4.50 percent for a fourth straight meeting on Wednesday, as they await clarity on whether tariffs would leave a one-time or more lasting mark on inflation. Powell said it is still unclear how much of the bill would fall on the shoulders of consumers, but he expects to learn more about tariffs
Greek tourism student Katerina quit within a month of starting work at a five-star hotel in Halkidiki, one of the country’s top destinations, because she said conditions were so dire. Beyond the bad pay, the 22-year-old said that her working and living conditions were “miserable and unacceptable.” Millions holiday in Greece every year, but its vital tourism industry is finding it harder and harder to recruit Greeks to look after them. “I was asked to work in any department of the hotel where there was a need, from service to cleaning,” said Katerina, a tourism and marketing student, who would
i Gasoline and diesel prices at fuel stations are this week to rise NT$0.1 per liter, as tensions in the Middle East pushed crude oil prices higher last week, CPC Corp, Taiwan (台灣中油) and Formosa Petrochemical Corp (台塑石化) said yesterday. International crude oil prices last week rose for the third consecutive week due to an escalating conflict between Israel and Iran, as the market is concerned that the situation in the Middle East might affect crude oil supply, CPC and Formosa said in separate statements. Front-month Brent crude oil futures — the international oil benchmark — rose 3.75 percent to settle at US$77.01